Sanomedics' Subsidiary Thermomedics, Inc. Reports 61% Sales Growth in 2014

MIAMI, March 24, 2015 /PRNewswire/ -- Sanomedics, Inc. (OTC: SIMH) an international medical technology company focused on developing, manufacturing, and acquiring cutting-edge technology, products and services, today reported preliminary, unaudited full year 2014 financial results for its wholly owned subsidiary Thermomedics, Inc., ("Thermomedics") a company dedicated to engineering, marketing and selling the Caregiver TouchFree™ Infrared thermometer.

Thermomedics Full Year 2014 Financial Highlights (Preliminary and Unaudited)

• Net sales for the full year of 2014 were $681,000, up 61% over $264,000 in 2013
• Gross profit for the full year of 2014 was $549,000 or 81% of revenues, up 51% over $205,000 or 78% of revenues in 2013

"We are encouraged by the performance of Thermomedics in 2014 as the company showed a tremendous growth in sales" stated Keith Houlihan, President and Founder of Sanomedics, Inc. "We expect 2015 to be a strong year for Thermomedics as we leverage our distribution partnerships with leading health services and products providers such as Alliant Healthcare, Henry Schein, McKesson and Kentec Medical. We have seen increased adoption of the Caregiver touch-free infrared thermometer in hospitals, clinics and private corporations around the world, and our strong performance in 2014 is a reflection of the growing demand for our device."

Ron Benincasa, Vice-President of Sales and Marketing of Thermomedics, stated "The Company has focused on completing National Account Contracts with the nation's largest healthcare GPO's and IDN's, leveraging the new protective protocols being implemented by virtually every provider facility in the country as we seek to protect clinical personnel and patients from exposure to the continuing threats from Ebola, MERS, Measles, Flu, and other contagious entities."

The preliminary financial information in this release is based on management's estimates derived from the information available at this time and is subject to revision upon finalization of the Company's completion of the annual audit.

About Sanomedics, Inc.
Sanomedics, Inc. (OTC: SIMH) is an international medical technology company focused on developing, manufacturing, and acquiring cutting-edge technology, products and services. The Company operates mainly through its subsidiary, Thermomedics, which is dedicated to engineering, marketing and selling the Caregiver TouchFree™ Infrared thermometer. The Caregiver non-contact thermometer is FDA-cleared in the United States for clinical use by medical professionals. The Caregiver provides an accurate and expedited temperature reading without direct contact between patient and medical professional. Sanomedics has established an extensive distribution network with several leading healthcare supply chain providers to increase adoption of the Caregiver device within the medical community worldwide.

Forward Looking Statements
Statements in this press release regarding Sanomedics that are not historical facts are forward- looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not directly or exclusively relate to historical facts. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "forecasts," "predicts," "potential," or the negative of those terms, and similar expressions and comparable terminology. These include, but are not limited to, statements relating to future events or our future financial and operating results, plans, objectives, expectations and intentions. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these expectations may not be achieved. Forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to known and unknown risks, uncertainties and other factors outside of our control that could cause our actual results, performance or achievement to differ materially from those expressed or implied by these forward-looking statements.

These forward-looking statements represent our estimates and assumptions only as of the date of this release and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this release. Given these uncertainties, you should not place undue reliance on these forward-looking statements and should consider various factors, including the risks described, among other places, in our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, as well as any amendments thereto, filed with the SEC.

Investor Contacts:
Phil Carlson / Thomas Mei
KCSA Strategic Communications
212-896-1233 / 212-896-1208
[email protected] / [email protected]

Media Contacts:
Chloe Font / Andrew Herweg
KCSA Strategic Communications
212-896-1287 / 212-896-1273
[email protected] / [email protected]

SOURCE Sanomedics, Inc.